Combination of traditional Chinese medicine and epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of non-small cell lung cancer: A systematic review and meta-analysis

BACKGROUND: In China, traditional Chinese medicine (TCM) is an increasingly important part of the treatment of non-small cell lung cancer (NSCLC), which usually includes a combination of prescription and syndrome differentiation. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Xinbing, Zhang, Mingming, Han, Xuemeng, Zhang, Ruonan, Chen, Liuxi, Liu, Ying, Xiang, Yu, Xie, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593038/
https://www.ncbi.nlm.nih.gov/pubmed/32769861
http://dx.doi.org/10.1097/MD.0000000000020683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593038/
https://www.ncbi.nlm.nih.gov/pubmed/32769861
http://dx.doi.org/10.1097/MD.0000000000020683

Ejemplares similares